保加利亚 - 保加利亚文 - БАБХ (Българска агенция по безопасност на храните)

norbrook laboratories (ireland) limited - Фипронил (с) - метопрен - разтвор за прилагане върху ограничен участък - 50 mg/0, 5 ml; 60 mg/0, 5 ml - котки, порове

保加利亚 - 保加利亚文 - Adama

adama - Разтворим концентат (СЛ) - 600 г/л 2,4 Д аминна сол - Хербициди

保加利亚 - 保加利亚文 - БАБХ (Българска агенция по безопасност на храните)

„ВЕТ ПРО КОМЕРС“ ООД - fipronil, praziquantel, pyroproxyfen, moxidectin - разтвор за прилагане върху ограничен участък - 107 mg/ml, 42.8 mg/ml, 21.4 mg/ml, 26.75 mg/ml - котки, кучета

保加利亚 - 保加利亚文 - БАБХ (Българска агенция по безопасност на храните)

„ВЕТ ПРО КОМЕРС“ ООД - fipronil, praziquantel, pyriproxyfen, moxidectin - разтвор за прилагане върху ограничен участък - 107 mg/ml, 42.8 mg/ml, 21.4 mg/ml, 10.7 mg/ml - котки, кучета

欧盟 - 保加利亚文 - EMA (European Medicines Agency)

ceva santé animale - инактивирана ваксина срещу coxiella burnetii, щам nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

欧盟 - 保加利亚文 - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - азацитидин - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - Антинеопластични средства - vidaza is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with: intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification. vidaza is indicated for the treatment of adult patients aged 65 years or older who are not eligible for hsct with aml with >30% marrow blasts according to the who classification.

欧盟 - 保加利亚文 - EMA (European Medicines Agency)

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - Антибактериални средства за подаване на заявления, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. Трябва да се вземат предвид официалните препоръки за правилното използване на антибактериални агенти.

欧盟 - 保加利亚文 - EMA (European Medicines Agency)

mylan pharmaceuticals limited - золедронова киселина - Фрактури, Кост - Лекарства за лечение на костни заболявания - Предотвратяване на събития, свързани с костната (патологични фрактури, степента на гръбначния мозък, излагане на радиация или хирургическа намеса върху костите, или тумор-индуцирана гиперкальциемии) при възрастни пациенти с късни етапи от жизнения злокачествени новообразувания с вовлечением кости;лечение на възрастни пациенти с тумор-индуцирана гиперкальциемии (tpu).

欧盟 - 保加利亚文 - EMA (European Medicines Agency)

celgene europe bv - азацитидин - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - Антинеопластични средства - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.

保加利亚 - 保加利亚文 - БАБХ (Българска агенция по безопасност на храните)

Сева Анимал Хелт България ЕООД - altrenogest - перорален разтвор - 4.0 mg/ml - свине